1. Utilising relevant analytical tools (e.g. Value chain, VRIN), critically analyse GSK's ownership advantages (Os), classifying them into Oa; Ot and Oi.

2. Internalisation advantages refer to the ability of a firm to leverage its ownership advantages abroad (e.g. the transfer of intangible assets, knowledge), how can GSK internalise its ownership advantages (Os identified in Q2) into Brazil?

3. With reference to different national culture frameworks (e.g. Hofstede, GLOBE, High-context vs low-context etc.), critically discuss both barriersandcompetitive advantagesby comparing the cross - culture differences between the UK and Brazil.

4. Drawing upon relevant innovation literature, critically discuss what type of innovation strategy GSK adopts, and what benefitsand challenges GSKcould face bybuilding its local innovation networks in Brazil?